Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Internal Medicine · SHOUB OAK, NY · NPI 1346323862
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 553 | 170 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 457 | 166 |
| Amlodipine Besylate | Amlodipine Besylate | 390 | 125 |
| Levothyroxine Sodium | Levothyroxine Sodium | 280 | 76 |
| Metoprolol Succinate | Metoprolol Succinate | 218 | 61 |
| Losartan Potassium | Losartan Potassium | 198 | 66 |
| Valsartan | Valsartan | 175 | 53 |
| Sertraline Hcl | Sertraline Hcl | 173 | 55 |
| Omeprazole | Omeprazole | 172 | 65 |
| Carvedilol | Carvedilol | 170 | 52 |
| Metformin Hcl | Metformin Hcl | 153 | 51 |
| Escitalopram Oxalate | Escitalopram Oxalate | 147 | 47 |
| Pantoprazole Sodium | Pantoprazole Sodium | 147 | 47 |
| Famotidine | Famotidine | 136 | 53 |
| Ozempic | Semaglutide | 135 | 23 |
| Simvastatin | Simvastatin | 133 | 50 |
| Hydrochlorothiazide | Hydrochlorothiazide | 112 | 37 |
| Lisinopril | Lisinopril | 111 | 32 |
| Trazodone Hcl | Trazodone Hcl | 110 | 33 |
| Fluticasone Propionate | Fluticasone Propionate | 98 | 59 |
| Nebivolol Hcl | Nebivolol Hcl | 95 | 20 |
| Cefuroxime | Cefuroxime Axetil | 94 | 76 |
| Furosemide | Furosemide | 90 | 35 |
| Gabapentin | Gabapentin | 90 | 41 |
| Mounjaro | Tirzepatide | 88 | 15 |
| Synthroid | Levothyroxine Sodium | 85 | 23 |
| Jardiance | Empagliflozin | 83 | 20 |
| Tamsulosin Hcl | Tamsulosin Hcl | 79 | 27 |
| Bupropion Xl | Bupropion Hcl | 78 | 23 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 76 | 22 |
| Xarelto | Rivaroxaban | 74 | 17 |
| Ezetimibe | Ezetimibe | 73 | 31 |
| Metformin Hcl Er | Metformin Hcl | 71 | 22 |
| Allopurinol | Allopurinol | 70 | 20 |
| Eliquis | Apixaban | 70 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 69 | 37 |
| Montelukast Sodium | Montelukast Sodium | 69 | 25 |
| Prednisone | Prednisone | 69 | 48 |
| Alprazolam | Alprazolam | 68 | 45 |
| Duloxetine Hcl | Duloxetine Hcl | 63 | 17 |
| Potassium Chloride | Potassium Chloride | 63 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 57 | 21 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 57 | 19 |
| Irbesartan | Irbesartan | 55 | 15 |
| Januvia | Sitagliptin Phosphate | 54 | 16 |
| Zolpidem Tartrate | Zolpidem Tartrate | 53 | 15 |
| Alendronate Sodium | Alendronate Sodium | 52 | 18 |
| Ramipril | Ramipril | 51 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 49 | 15 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 48 | 15 |
| Telmisartan | Telmisartan | 45 | suppressed |
| Meloxicam | Meloxicam | 44 | 25 |
| Paroxetine Hcl | Paroxetine Hcl | 44 | 12 |
| Methylprednisolone | Methylprednisolone | 42 | 39 |
| Azithromycin | Azithromycin | 39 | 30 |
| Mirtazapine | Mirtazapine | 39 | 21 |
| Glimepiride | Glimepiride | 37 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 37 | 11 |
| Mometasone Furoate | Mometasone Furoate | 37 | 31 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 37 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 36 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 36 | 26 |
| Klor-Con M20 | Potassium Chloride | 35 | 13 |
| Lovastatin | Lovastatin | 32 | suppressed |
| Finasteride | Finasteride | 31 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 31 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 31 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 31 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 30 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 30 | suppressed |
| Clonazepam | Clonazepam | 29 | 15 |
| Chlorthalidone | Chlorthalidone | 28 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 28 | 21 |
| Valacyclovir | Valacyclovir Hcl | 27 | 11 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 26 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 24 | 15 |
| Linzess | Linaclotide | 24 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 23 | suppressed |
| Lansoprazole | Lansoprazole | 23 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 22 | 16 |
| Enalapril Maleate | Enalapril Maleate | 21 | suppressed |
| Trulicity | Dulaglutide | 21 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 20 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 20 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 20 | 18 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 20 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 20 | suppressed |
| Spironolactone | Spironolactone | 20 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 20 | 16 |
| Diazepam | Diazepam | 19 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Torsemide | Torsemide | 19 | suppressed |
| Lorazepam | Lorazepam | 18 | 12 |
| Nystatin | Nystatin | 18 | 12 |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 17 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 17 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 17 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 16 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 16 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 15 |
| Risedronate Sodium | Risedronate Sodium | 16 | suppressed |
| Carbamazepine Er | Carbamazepine | 15 | suppressed |
| Cefdinir | Cefdinir | 15 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 15 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 15 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 15 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 14 | suppressed |
| Nifedipine Er | Nifedipine | 14 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 14 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 14 | suppressed |
| Tradjenta | Linagliptin | 14 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 13 | suppressed |
| Folic Acid | Folic Acid | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 13 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Wegovy | Semaglutide | 13 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Ondansetron Odt | Ondansetron | 12 | 12 |
| Praluent Pen | Alirocumab | 12 | suppressed |
| Vemlidy | Tenofovir Alafenamide | 12 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Pregabalin | Pregabalin | 11 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error